Sherbrooke Park Advisers’s Arbutus Biopharma ABUS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$66.8K	Buy	+21,634	New	+$66.8K	0.03%	486
2024 Q4	–	Sell	-67,455	Closed	-$260K	–	721
2024 Q3	$260K	Buy	67,455 +25,841	+62%	+$99.5K	0.06%	636
2024 Q2	$129K	Buy	+41,614	New	+$129K	0.02%	815